Lucas Dennis, PhD, Senior Vice President, Head of Research and Development

Lucas Dennis, PhD, is Senior Vice President, Head of Research and Development at Foundation Medicine. In his role, Dennis oversees early-stage research, computational discovery and diagnostic product development and is responsible for ensuring the advancement of the company’s cancer diagnostic portfolio.

Foundation Medicine’s Computational Biology team (Comp Bio) is an interdisciplinary group that develops innovative diagnostic tools using the latest advancements in science. Their work drives the transformation of cancer care and helps distinguish our company as leaders in the industry. Comprised of computational biologists, molecular biologists, software engineers and other skilled specialists, the team leverages their wide range of expertise with our robust datasets to enhance our understanding of next generation sequencing (NGS). Gain insight from three Principal Scientists about Comp Bio’s role in driving innovation at our company.

Read more about Comp Bio in this blog.

When the Diagnostic Development and Validation (DD&V) Team at Foundation Medicine arrives for work each day, they are stepping into roles that epitomize the company’s value of collaboration. The team operates as a bridge between Product Development and Laboratory Operations through their focus on late-stage product development, validation, and transfer of knowledge. The team’s mission is to ensure that Foundation Medicine’s laboratory tests are safe and effective, enabling important diagnostic insights for partners and patients. Their collaboration with different partners across the company contributes to technical expertise within Foundation Medicine’s design and development process for new and existing products.

Learn more about DD&V here.

If you’re looking for a team at Foundation Medicine with a cross-functional reach, you need not look any further than the Regulatory Affairs team. Operating within our Research and Development (R&D) function, the team serves a critical role as a collaborative, results-driven partner, driving development and supporting the launch of transformational products, as well as influencing the global regulatory and policy environment in which they operate. They offer key insights, strategy, and support to bring our products to market, serving our patients, physicians, and research partners both in the U.S. and in ex-U.S. markets.

Learn more about Regulatory Affairs here.